METFORMIN

METFORMIN was reported 303369 times

METFORMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACTIC ACIDOSIS 17631 0.5439
1 NEUROLOGIC NEGLECT SYNDROME 291 0.5234
2 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1872 0.4529
3 PULMONARY VASCULITIS 240 0.4461
4 CAROTID ARTERY THROMBOSIS 299 0.3522
5 DIABETIC METABOLIC DECOMPENSATION 473 0.3405
6 HYPERLACTACIDAEMIA 824 0.3070
7 ADJUSTMENT DISORDER 304 0.2338
8 METABOLIC ACIDOSIS 6318 0.1974
9 KETOACIDOSIS 1373 0.1833
10 ANION GAP INCREASED 244 0.1824
11 GLYCOSYLATED HAEMOGLOBIN INCREASED 4585 0.1815
12 GASTROINTESTINAL HYPOMOTILITY 404 0.1791
13 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 213 0.1778
14 HYPOGLYCAEMIC COMA 511 0.1771
15 DIABETIC KETOACIDOSIS 4125 0.1716
16 DIABETES MELLITUS INADEQUATE CONTROL 2951 0.1665
17 VITAMIN B12 DEFICIENCY 657 0.1621
18 NEURITIS 239 0.1547
19 HYPOGLYCAEMIA 7443 0.1533
20 GLYCOSYLATED HAEMOGLOBIN DECREASED 246 0.1527
21 DISTRIBUTIVE SHOCK 327 0.1442
22 IMPAIRED GASTRIC EMPTYING 1895 0.1389
23 BLOOD LACTIC ACID INCREASED 730 0.1384
24 DIABETIC NEUROPATHY 684 0.1380
25 PERSONALITY DISORDER 347 0.1323
26 BLOOD BICARBONATE DECREASED 245 0.1293
27 SUSPECTED SUICIDE 578 0.1232
28 HYPERPARATHYROIDISM SECONDARY 295 0.1176
29 BLOOD PRESSURE DIASTOLIC ABNORMAL 298 0.1170
30 DIABETIC RETINOPATHY 396 0.1165
31 ACUTE KIDNEY INJURY 17717 0.1157
32 NEPHROGENIC ANAEMIA 536 0.1156
33 BLOOD GLUCOSE FLUCTUATION 1264 0.1152
34 HYPERKALAEMIA 4016 0.1144
35 BLOOD GLUCOSE ABNORMAL 2070 0.1120
36 INSULIN RESISTANCE 232 0.1114
37 FORCED EXPIRATORY VOLUME DECREASED 308 0.1086
38 DRUG LEVEL ABOVE THERAPEUTIC 473 0.1032
39 PANCREATIC CARCINOMA METASTATIC 290 0.1019
40 HYPOVOLAEMIA 584 0.0997
41 BLOOD GLUCOSE INCREASED 18748 0.0994
42 HYPERGLYCAEMIA 3607 0.0989
43 ANURIA 847 0.0983
44 BLOOD PRESSURE SYSTOLIC ABNORMAL 240 0.0970
45 PEMPHIGOID 724 0.0958
46 INJECTION SITE NODULE 1039 0.0943
47 BLOOD GLUCOSE DECREASED 4504 0.0937
48 RESPIRATORY SYMPTOM 264 0.0927
49 POTENTIATING DRUG INTERACTION 306 0.0911
50 IMMUNE-MEDIATED MYOSITIS 249 0.0903
51 REBOUND ACID HYPERSECRETION 271 0.0895
52 ACIDOSIS 670 0.0876
53 PERIPHERAL VENOUS DISEASE 358 0.0876
54 SHOCK 1998 0.0868
55 HYPOMAGNESAEMIA 1206 0.0865
56 FACET JOINT SYNDROME 276 0.0847
57 NORMOCHROMIC NORMOCYTIC ANAEMIA 254 0.0845
58 DIABETIC FOOT 254 0.0829
59 VITAMIN B12 DECREASED 236 0.0818
60 ONYCHOMADESIS 341 0.0812
61 ONYCHOMYCOSIS 344 0.0783
62 RALES 440 0.0757
63 HYPOTHERMIA 765 0.0755
64 INTENTIONAL DEVICE MISUSE 333 0.0755
65 DRUG LEVEL INCREASED 1244 0.0751
66 HYPOVOLAEMIC SHOCK 359 0.0749
67 BLOOD PRESSURE SYSTOLIC INCREASED 1456 0.0746
68 BLOOD PRESSURE DIASTOLIC DECREASED 550 0.0744
69 TYPE 2 DIABETES MELLITUS 2441 0.0724
70 PANCREATITIS ACUTE 1626 0.0723
71 ARTERIOSCLEROSIS CORONARY ARTERY 479 0.0722
72 GANGRENE 431 0.0715
73 HYPOPNOEA 244 0.0702
74 ABNORMAL LOSS OF WEIGHT 468 0.0686
75 WOUND COMPLICATION 232 0.0675
76 POLYURIA 545 0.0665
77 NECROTISING FASCIITIS 234 0.0663
78 DIABETES MELLITUS 5040 0.0661
79 DYSLIPIDAEMIA 333 0.0655
80 OBSTRUCTIVE AIRWAYS DISORDER 728 0.0654
81 PULSELESS ELECTRICAL ACTIVITY 272 0.0650
82 HEMIPLEGIA 536 0.0644
83 BRONCHIECTASIS 433 0.0642
84 SENSORY LOSS 512 0.0635
85 RENAL TUBULAR NECROSIS 621 0.0632
86 HAEMODYNAMIC INSTABILITY 479 0.0628
87 HEPATIC STEATOSIS 1168 0.0626
88 BODY TEMPERATURE DECREASED 613 0.0622
89 POLYDIPSIA 246 0.0622
90 NEUROLOGICAL SYMPTOM 349 0.0610
91 LEFT VENTRICULAR HYPERTROPHY 259 0.0605
92 OBESITY 961 0.0603
93 GLOMERULAR FILTRATION RATE DECREASED 739 0.0601
94 RED CELL DISTRIBUTION WIDTH INCREASED 246 0.0591
95 PSYCHOLOGICAL TRAUMA 508 0.0588
96 TOE AMPUTATION 297 0.0584
97 OLIGURIA 358 0.0576
98 CHRONIC KIDNEY DISEASE 4379 0.0576
99 OVERWEIGHT 309 0.0575
100 FULL BLOOD COUNT ABNORMAL 606 0.0572
101 INJECTION SITE EXTRAVASATION 704 0.0570
102 FINGER DEFORMITY 275 0.0567
103 HAIR DISORDER 467 0.0566
104 ARTERIAL OCCLUSIVE DISEASE 442 0.0562
105 BLEPHAROSPASM 354 0.0562
106 TUBULOINTERSTITIAL NEPHRITIS 1041 0.0555
107 LIPASE INCREASED 424 0.0553
108 END STAGE RENAL DISEASE 989 0.0542
109 LEFT VENTRICULAR DYSFUNCTION 363 0.0541
110 UROSEPSIS 495 0.0536
111 C-REACTIVE PROTEIN ABNORMAL 342 0.0533
112 RHEUMATIC FEVER 237 0.0531
113 BLOOD MAGNESIUM DECREASED 458 0.0530
114 PANCREATITIS 2798 0.0529
115 GLUCOSE TOLERANCE IMPAIRED 312 0.0527
116 MYOPATHY 449 0.0519
117 ARTERIOSCLEROSIS 489 0.0519
118 ERUCTATION 1000 0.0516
119 CARDIAC FAILURE CHRONIC 220 0.0516
120 HAEMODIALYSIS 426 0.0507
121 PULMONARY ALVEOLAR HAEMORRHAGE 282 0.0502
122 BUNDLE BRANCH BLOCK LEFT 212 0.0499
123 MEDICATION RESIDUE PRESENT 238 0.0498
124 HAEMORRHAGIC ANAEMIA 219 0.0498
125 BURSITIS 600 0.0494
126 INJECTION SITE MASS 1818 0.0491
127 ATRIOVENTRICULAR BLOCK FIRST DEGREE 212 0.0489
128 TACHYPNOEA 662 0.0486
129 BLOOD CHOLESTEROL ABNORMAL 221 0.0478
130 PAROSMIA 360 0.0477
131 EXERCISE TOLERANCE DECREASED 274 0.0476
132 BACK INJURY 515 0.0473
133 HYPERCHOLESTEROLAEMIA 457 0.0473
134 BREATH SOUNDS ABNORMAL 233 0.0472
135 HAIR COLOUR CHANGES 585 0.0470
136 RENAL CYST 372 0.0468
137 RHINITIS 377 0.0467
138 ACUTE CORONARY SYNDROME 387 0.0467
139 MOTOR DYSFUNCTION 475 0.0466
140 TOXIC ENCEPHALOPATHY 236 0.0465
141 BLOOD IRON DECREASED 549 0.0462
142 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1307 0.0461
143 ANAL INCONTINENCE 413 0.0459
144 SLEEP APNOEA SYNDROME 876 0.0459
145 APPETITE DISORDER 303 0.0457
146 RENAL FAILURE 6043 0.0455
147 AFFECT LABILITY 437 0.0454
148 LEUKOCYTOSIS 819 0.0452
149 CORONARY ARTERY STENOSIS 227 0.0451
150 BLOOD TRIGLYCERIDES INCREASED 797 0.0451
151 SYNOVITIS 811 0.0449
152 CARDIAC MURMUR 389 0.0449
153 WEIGHT DECREASED 12456 0.0446
154 FLANK PAIN 417 0.0444
155 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 754 0.0444
156 TOXICITY TO VARIOUS AGENTS 7484 0.0443
157 CARDIOGENIC SHOCK 627 0.0437
158 DEHYDRATION 5828 0.0436
159 RENAL FAILURE ACUTE 1852 0.0436
160 BLOOD POTASSIUM INCREASED 708 0.0436
161 ACUTE MYOCARDIAL INFARCTION 1284 0.0435
162 TASTE DISORDER 882 0.0434
163 ACCIDENTAL UNDERDOSE 625 0.0434
164 JOINT RANGE OF MOTION DECREASED 581 0.0433
165 ELECTROLYTE IMBALANCE 502 0.0432
166 ATRIOVENTRICULAR BLOCK COMPLETE 289 0.0431
167 NEPHROPATHY 403 0.0431
168 CHOLELITHIASIS 1415 0.0431
169 POLYP 281 0.0429
170 EATING DISORDER 912 0.0428
171 ATRIOVENTRICULAR BLOCK 331 0.0428
172 HYPERLIPIDAEMIA 508 0.0425
173 THIRST 754 0.0422
174 OSTEOARTHRITIS 1787 0.0421
175 METABOLIC DISORDER 244 0.0420
176 BLINDNESS TRANSIENT 309 0.0419
177 PRODUCT ODOUR ABNORMAL 438 0.0418
178 ELECTROCARDIOGRAM ABNORMAL 328 0.0418
179 COMPLETED SUICIDE 3481 0.0417
180 RHABDOMYOLYSIS 1741 0.0417
181 GASTROENTERITIS 608 0.0416
182 HYPOPHAGIA 1061 0.0415
183 POLLAKIURIA 1729 0.0414
184 CORONARY ARTERY OCCLUSION 566 0.0412
185 HEPATIC CIRRHOSIS 775 0.0412
186 PARKINSONISM 402 0.0412
187 GINGIVAL PAIN 328 0.0412
188 ANGINA PECTORIS 1180 0.0411
189 FOLLICULITIS 428 0.0408
190 HEMIPARESIS 691 0.0408
191 CIRCULATORY COLLAPSE 692 0.0406
192 BREAST CANCER STAGE III 263 0.0406
193 VASCULITIS 472 0.0405
194 INTESTINAL ISCHAEMIA 223 0.0405
195 MUSCLE INJURY 335 0.0404
196 CONTRAINDICATED PRODUCT ADMINISTERED 1224 0.0404
197 LARGE INTESTINE POLYP 280 0.0404
198 CORONARY ARTERY DISEASE 1223 0.0403
199 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 357 0.0403
200 HAIR TEXTURE ABNORMAL 538 0.0402
201 DRUG INTERACTION 6379 0.0402
202 NOCTURIA 487 0.0401
203 DECREASED APPETITE 9314 0.0401
204 EXOSTOSIS 366 0.0400
205 MITRAL VALVE INCOMPETENCE 453 0.0400
206 SPUTUM DISCOLOURED 379 0.0399
207 SINUS CONGESTION 539 0.0399
208 BLOOD PRESSURE INADEQUATELY CONTROLLED 240 0.0399
209 RENAL INJURY 1185 0.0399
210 C-REACTIVE PROTEIN INCREASED 1451 0.0398
211 BLOOD CREATININE INCREASED 2584 0.0395
212 HYPERTRIGLYCERIDAEMIA 231 0.0394
213 NODULE 513 0.0393
214 IMPAIRED QUALITY OF LIFE 564 0.0392
215 NAIL DISORDER 343 0.0392
216 SOPOR 519 0.0391
217 HYPONATRAEMIA 2203 0.0391
218 CHOLECYSTITIS 464 0.0389
219 PULMONARY FIBROSIS 747 0.0389
220 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 279 0.0389
221 MADAROSIS 451 0.0388
222 ANGINA UNSTABLE 252 0.0387
223 SCIATICA 615 0.0385
224 IRON DEFICIENCY ANAEMIA 356 0.0385
225 DYSPNOEA EXERTIONAL 1446 0.0384
226 TROPONIN INCREASED 292 0.0383
227 FUNGAL INFECTION 1279 0.0383
228 WOUND INFECTION 420 0.0383
229 MYOCARDIAL ISCHAEMIA 436 0.0383
230 CATARACT 2275 0.0382
231 BLOOD CHOLESTEROL INCREASED 1779 0.0381
232 HYPOCALCAEMIA 720 0.0380
233 HYPOKINESIA 551 0.0379
234 BLOOD PRESSURE FLUCTUATION 911 0.0379
235 COORDINATION ABNORMAL 528 0.0378
236 WOUND 1058 0.0378
237 GAIT INABILITY 1259 0.0376
238 HUNGER 524 0.0376
239 NEUTROPHIL COUNT INCREASED 385 0.0376
240 BODY HEIGHT DECREASED 402 0.0376
241 RENAL IMPAIRMENT 3136 0.0373
242 INTENTIONAL OVERDOSE 2387 0.0372
243 DYSARTHRIA 1400 0.0372
244 ACCIDENTAL OVERDOSE 1353 0.0369
245 ORTHOSTATIC HYPOTENSION 644 0.0369
246 SINUS DISORDER 732 0.0369
247 UPPER GASTROINTESTINAL HAEMORRHAGE 621 0.0369
248 PERICARDITIS 620 0.0369
249 RED BLOOD CELL SEDIMENTATION RATE INCREASED 408 0.0368
250 DUODENAL ULCER 260 0.0368
251 URINE OUTPUT DECREASED 319 0.0365
252 BLOOD URINE PRESENT 690 0.0363
253 DRUG-INDUCED LIVER INJURY 1139 0.0363
254 FAECES SOFT 264 0.0363
255 DIARRHOEA 23425 0.0363
256 PYELONEPHRITIS 313 0.0361
257 GASTROOESOPHAGEAL REFLUX DISEASE 2906 0.0361
258 SKIN HAEMORRHAGE 535 0.0361
259 DYSURIA 1328 0.0360
260 INJECTION SITE HAEMORRHAGE 2879 0.0360
261 BLADDER CANCER 2118 0.0359
262 RESPIRATORY RATE INCREASED 319 0.0359
263 ACUTE RESPIRATORY FAILURE 691 0.0359
264 CYSTITIS 1141 0.0358
265 HYPOTENSION 7163 0.0357
266 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 366 0.0356
267 HAEMATURIA 1220 0.0356
268 SKIN ULCER 919 0.0355
269 HYPOKALAEMIA 1632 0.0353
270 PRODUCTIVE COUGH 1687 0.0353
271 PEMPHIGUS 441 0.0352
272 TRICUSPID VALVE INCOMPETENCE 280 0.0352
273 BRADYCARDIA 1869 0.0352
274 WHEEZING 2087 0.0352
275 RESPIRATORY TRACT CONGESTION 559 0.0351
276 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1688 0.0351
277 CARPAL TUNNEL SYNDROME 492 0.0351
278 MELAENA 772 0.0350
279 WEIGHT FLUCTUATION 366 0.0349
280 MENISCUS INJURY 215 0.0349
281 HYPOTHYROIDISM 1116 0.0349
282 LOCALISED INFECTION 845 0.0349
283 DYSPEPSIA 3434 0.0349
284 GRIP STRENGTH DECREASED 307 0.0348
285 BLOOD UREA INCREASED 584 0.0348
286 NEPHROLITHIASIS 1593 0.0347
287 DUODENAL ULCER PERFORATION 258 0.0347
288 LOWER GASTROINTESTINAL HAEMORRHAGE 256 0.0346
289 ATRIAL FLUTTER 275 0.0344
290 GOUT 616 0.0343
291 MYOSITIS 308 0.0343
292 EYE HAEMORRHAGE 457 0.0342
293 LOWER RESPIRATORY TRACT INFECTION 1555 0.0342
294 CONCOMITANT DISEASE AGGRAVATED 211 0.0342
295 SEASONAL ALLERGY 483 0.0341
296 MICTURITION URGENCY 387 0.0338
297 VOMITING 15929 0.0338
298 NERVE COMPRESSION 312 0.0338
299 HYPERTENSIVE CRISIS 376 0.0338
300 ATRIAL FIBRILLATION 3281 0.0337
301 LIMB INJURY 912 0.0335
302 CONFUSIONAL STATE 5422 0.0335
303 IRRITABLE BOWEL SYNDROME 718 0.0335
304 EJECTION FRACTION DECREASED 520 0.0334
305 URINARY INCONTINENCE 990 0.0334
306 SINUS BRADYCARDIA 323 0.0334
307 SINUS TACHYCARDIA 474 0.0333
308 CELLULITIS 1681 0.0333
309 RENAL PAIN 353 0.0333
310 LIP DRY 302 0.0332
311 FLATULENCE 1885 0.0332
312 RESPIRATION ABNORMAL 229 0.0332
313 VITAMIN D DEFICIENCY 324 0.0332
314 DIZZINESS POSTURAL 322 0.0332
315 BLOOD PRESSURE INCREASED 5069 0.0331
316 MUSCLE SPASTICITY 407 0.0331
317 FIBROMYALGIA 805 0.0331
318 COVID-19 PNEUMONIA 390 0.0330
319 HYPOPHOSPHATAEMIA 243 0.0328
320 PSORIATIC ARTHROPATHY 1333 0.0328
321 PULMONARY MASS 488 0.0327
322 LIVE BIRTH 273 0.0326
323 DECREASED ACTIVITY 352 0.0326
324 ABDOMINAL DISCOMFORT 5441 0.0324
325 PERIPHERAL SWELLING 4980 0.0323
326 BLOOD PRESSURE ABNORMAL 640 0.0322
327 HYPERCALCAEMIA 397 0.0321
328 BLOOD SODIUM DECREASED 604 0.0320
329 PHARYNGITIS 397 0.0320
330 GLAUCOMA 615 0.0319
331 BLOOD POTASSIUM DECREASED 959 0.0319
332 URINARY TRACT INFECTION 5392 0.0316
333 OXYGEN SATURATION DECREASED 1775 0.0316
334 ROTATOR CUFF SYNDROME 404 0.0314
335 ABDOMINAL PAIN 7301 0.0314
336 APHASIA 947 0.0313
337 UNRESPONSIVE TO STIMULI 808 0.0313
338 MENTAL STATUS CHANGES 867 0.0312
339 HEPATIC CYTOLYSIS 398 0.0312
340 MUSCULAR WEAKNESS 3538 0.0311
341 ENCEPHALOPATHY 764 0.0311
342 JOINT INJURY 662 0.0310
343 DIVERTICULUM 220 0.0309
344 FREQUENT BOWEL MOVEMENTS 836 0.0309
345 TRANSIENT ISCHAEMIC ATTACK 1044 0.0309
346 ARTHRITIS 2433 0.0309
347 INTERVERTEBRAL DISC DEGENERATION 286 0.0309
348 CONSTIPATION 6724 0.0308
349 DIVERTICULITIS 854 0.0308
350 FEEDING DISORDER 625 0.0308
351 HAND DEFORMITY 404 0.0308
352 ABDOMINAL DISTENSION 3214 0.0308
353 ISCHAEMIC STROKE 549 0.0307
354 OSTEOMYELITIS 557 0.0307
355 INTERVERTEBRAL DISC PROTRUSION 672 0.0307
356 MUSCULOSKELETAL PAIN 1609 0.0307
357 VENTRICULAR FIBRILLATION 341 0.0307
358 HAEMORRHAGIC STROKE 239 0.0306
359 ABDOMINAL PAIN UPPER 6297 0.0306
360 MUSCLE ATROPHY 387 0.0305
361 BASAL CELL CARCINOMA 476 0.0305
362 CARDIAC ARREST 2518 0.0305
363 LIGAMENT SPRAIN 301 0.0304
364 SPINAL OSTEOARTHRITIS 267 0.0304
365 GASTROINTESTINAL DISORDER 2715 0.0303
366 DYSSTASIA 879 0.0301
367 GASTRITIS 792 0.0301
368 SWOLLEN TONGUE 940 0.0301
369 PRODUCT PRESCRIBING ERROR 716 0.0300
370 HEART RATE DECREASED 1053 0.0300
371 MUSCULOSKELETAL CHEST PAIN 464 0.0299
372 SYNCOPE 2996 0.0299
373 INCREASED APPETITE 572 0.0299
374 CARDIOMEGALY 368 0.0299
375 HIATUS HERNIA 386 0.0298
376 HYPERTENSION 6302 0.0297
377 FALL 9886 0.0297
378 PRODUCT ADMINISTRATION INTERRUPTED 233 0.0297
379 LUNG DISORDER 1449 0.0295
380 NAUSEA 23351 0.0295
381 RETCHING 629 0.0295
382 ASTHENIA 11053 0.0294
383 CANDIDA INFECTION 496 0.0293
384 ELECTROCARDIOGRAM QT PROLONGED 1055 0.0293
385 VENTRICULAR TACHYCARDIA 484 0.0293
386 RECTAL HAEMORRHAGE 1259 0.0293
387 HELICOBACTER INFECTION 300 0.0292
388 EOSINOPHILIA 511 0.0291
389 CARDIAC FAILURE 2340 0.0291
390 TOOTH ABSCESS 296 0.0290
391 TENDERNESS 302 0.0289
392 FRUSTRATION TOLERANCE DECREASED 234 0.0289
393 PRESYNCOPE 704 0.0289
394 HEPATOMEGALY 283 0.0288
395 MALNUTRITION 321 0.0287
396 SEPTIC SHOCK 1245 0.0286
397 COLD SWEAT 504 0.0286
398 MEDICATION ERROR 1589 0.0286
399 INCONTINENCE 302 0.0285
400 LOW DENSITY LIPOPROTEIN INCREASED 221 0.0285
401 SUPRAVENTRICULAR TACHYCARDIA 273 0.0285
402 SHOCK HAEMORRHAGIC 232 0.0285
403 ALTERED STATE OF CONSCIOUSNESS 617 0.0285
404 URINARY RETENTION 948 0.0284
405 BLOOD CREATINE PHOSPHOKINASE INCREASED 816 0.0283
406 MULTIPLE ALLERGIES 222 0.0283
407 VENTRICULAR EXTRASYSTOLES 294 0.0283
408 HAEMATEMESIS 717 0.0283
409 INTERNAL HAEMORRHAGE 323 0.0282
410 IMPAIRED HEALING 928 0.0282
411 GASTROINTESTINAL HAEMORRHAGE 2360 0.0282
412 LIVER FUNCTION TEST INCREASED 606 0.0282
413 TOOTH INFECTION 372 0.0282
414 UNDERDOSE 2058 0.0282
415 RETINAL DETACHMENT 259 0.0281
416 FACIAL PARALYSIS 240 0.0281
417 SKIN LACERATION 306 0.0281
418 SNEEZING 631 0.0281
419 MIDDLE INSOMNIA 525 0.0281
420 GLOSSODYNIA 629 0.0281
421 NIGHT SWEATS 905 0.0281
422 TOOTHACHE 508 0.0280
423 HAEMATOCRIT DECREASED 556 0.0280
424 HEAD INJURY 887 0.0280
425 HYPOXIA 985 0.0279
426 WHITE BLOOD CELL COUNT INCREASED 1073 0.0279
427 GENERAL PHYSICAL HEALTH DETERIORATION 3235 0.0279
428 DRY MOUTH 2261 0.0278
429 COMA 1325 0.0278
430 WEIGHT INCREASED 6230 0.0278
431 FEELING COLD 772 0.0277
432 NEEDLE ISSUE 807 0.0277
433 FAECES DISCOLOURED 601 0.0277
434 SALIVARY HYPERSECRETION 277 0.0277
435 BRONCHITIS 2048 0.0276
436 BALANCE DISORDER 2385 0.0276
437 INABILITY TO AFFORD MEDICATION 274 0.0276
438 RENAL DISORDER 1285 0.0276
439 BOWEL MOVEMENT IRREGULARITY 211 0.0275
440 VITAMIN D DECREASED 235 0.0275
441 EAR PAIN 534 0.0274
442 GASTRIC ULCER 522 0.0274
443 HEART RATE INCREASED 2718 0.0274
444 LIVER INJURY 672 0.0273
445 BLISTER 1537 0.0273
446 HAEMATOMA 709 0.0273
447 AGEUSIA 681 0.0273
448 RHINORRHOEA 1763 0.0272
449 INFLUENZA 3036 0.0272
450 MYOCARDITIS 312 0.0272
451 RESPIRATORY FAILURE 1984 0.0272
452 HYPERHIDROSIS 3503 0.0272
453 KIDNEY INFECTION 532 0.0271
454 GROIN PAIN 238 0.0271
455 IMPAIRED WORK ABILITY 579 0.0271
456 COAGULOPATHY 451 0.0270
457 ASTHMA 3053 0.0270
458 HEART RATE IRREGULAR 610 0.0270
459 PROSTATIC SPECIFIC ANTIGEN INCREASED 371 0.0269
460 ATELECTASIS 260 0.0269
461 HAEMOLYTIC ANAEMIA 241 0.0269
462 SUBARACHNOID HAEMORRHAGE 274 0.0269
463 PAIN IN EXTREMITY 7924 0.0269
464 INTENTIONAL PRODUCT USE ISSUE 2354 0.0268
465 COUGH 7527 0.0268
466 MASS 375 0.0268
467 CYST 333 0.0268
468 MOBILITY DECREASED 1926 0.0268
469 SLEEP DISORDER 1887 0.0267
470 OEDEMA PERIPHERAL 3257 0.0267
471 ILEUS 332 0.0267
472 NERVE INJURY 297 0.0267
473 VISUAL IMPAIRMENT 3310 0.0267
474 HAEMOPTYSIS 745 0.0267
475 ANAEMIA 5089 0.0267
476 CARDIOMYOPATHY 393 0.0266
477 BLOOD COUNT ABNORMAL 403 0.0266
478 PULMONARY CONGESTION 350 0.0265
479 CARDIAC FAILURE CONGESTIVE 2130 0.0265
480 RED BLOOD CELL COUNT DECREASED 758 0.0265
481 SEPSIS 2952 0.0264
482 BLINDNESS UNILATERAL 372 0.0263
483 EXPOSURE DURING PREGNANCY 1637 0.0263
484 PULMONARY OEDEMA 1178 0.0263
485 NECK PAIN 1469 0.0263
486 SLUGGISHNESS 268 0.0262
487 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1370 0.0262
488 HEPATIC ENZYME INCREASED 1786 0.0262
489 ANGIOEDEMA 1159 0.0262
490 ARTHROPATHY 1456 0.0262
491 BLOOD PRESSURE DECREASED 1737 0.0261
492 LETHARGY 1502 0.0261
493 HAEMORRHOIDS 508 0.0260
494 SUICIDE ATTEMPT 1577 0.0260
495 PANCREATIC CARCINOMA 751 0.0260
496 TACHYCARDIA 2306 0.0259
497 INTERNATIONAL NORMALISED RATIO INCREASED 740 0.0259
498 CHEST PAIN 4805 0.0259
499 DECUBITUS ULCER 211 0.0259
500 METASTASES TO LIVER 455 0.0259
501 GAMMA-GLUTAMYLTRANSFERASE INCREASED 573 0.0258
502 DIZZINESS 12895 0.0258
503 HICCUPS 212 0.0258
504 RIB FRACTURE 531 0.0258
505 INTENTIONAL PRODUCT MISUSE 2259 0.0258
506 HIDRADENITIS 235 0.0257
507 GAIT DISTURBANCE 4928 0.0257
508 NEUROPATHY PERIPHERAL 2449 0.0257
509 POOR QUALITY SLEEP 554 0.0257
510 ANKLE FRACTURE 398 0.0257
511 SCHIZOPHRENIA 312 0.0256
512 LIMB DISCOMFORT 794 0.0256
513 ABSCESS 408 0.0255
514 FACIAL PAIN 228 0.0255
515 MEMORY IMPAIRMENT 3506 0.0255
516 GASTROENTERITIS VIRAL 460 0.0255
517 HERNIA 492 0.0254
518 SPINAL PAIN 298 0.0254
519 PERIPHERAL COLDNESS 349 0.0254
520 NEURALGIA 618 0.0254
521 BACK PAIN 5901 0.0254
522 DISORIENTATION 1005 0.0253
523 LIP SWELLING 843 0.0253
524 CHEST DISCOMFORT 2592 0.0253
525 JOINT SWELLING 3055 0.0253
526 HYPERTHYROIDISM 366 0.0253
527 BACK DISORDER 410 0.0252
528 DYSPNOEA 14259 0.0252
529 PREMATURE DELIVERY 401 0.0252
530 SPINAL DISORDER 238 0.0251
531 HEPATITIS 643 0.0251
532 DELIRIUM 872 0.0251
533 BLOOD THYROID STIMULATING HORMONE INCREASED 231 0.0251
534 VERTIGO 1528 0.0250
535 TOOTH FRACTURE 276 0.0250
536 ASPIRATION 274 0.0250
537 OROPHARYNGEAL PAIN 2312 0.0250
538 UPPER RESPIRATORY TRACT INFECTION 1152 0.0249
539 SPLENOMEGALY 291 0.0248
540 DYSGEUSIA 1844 0.0248
541 INJECTION SITE DISCOMFORT 261 0.0248
542 GASTROINTESTINAL PAIN 273 0.0248
543 MALAISE 10863 0.0247
544 INITIAL INSOMNIA 254 0.0247
545 SECRETION DISCHARGE 310 0.0247
546 TREATMENT NONCOMPLIANCE 1350 0.0246
547 POOR VENOUS ACCESS 255 0.0246
548 ULCER 392 0.0246
549 DEPRESSED LEVEL OF CONSCIOUSNESS 974 0.0246
550 PLATELET COUNT INCREASED 321 0.0246
551 SMALL INTESTINAL OBSTRUCTION 303 0.0246
552 MUSCLE SPASMS 4513 0.0246
553 SKIN LESION 674 0.0245
554 HAEMOGLOBIN DECREASED 2518 0.0245
555 RESPIRATORY DISTRESS 675 0.0244
556 LOSS OF CONSCIOUSNESS 3127 0.0244
557 PROTEINURIA 463 0.0243
558 INCORRECT PRODUCT STORAGE 320 0.0243
559 LIVER FUNCTION TEST ABNORMAL 706 0.0243
560 NASOPHARYNGITIS 4474 0.0242
561 FOOT DEFORMITY 268 0.0242
562 SUBDURAL HAEMATOMA 346 0.0241
563 INFLAMMATION 1247 0.0241
564 POISONING DELIBERATE 229 0.0241
565 CEREBROVASCULAR ACCIDENT 4084 0.0241
566 NEOPLASM 277 0.0241
567 SINUSITIS 2469 0.0241
568 ACUTE HEPATIC FAILURE 329 0.0241
569 PALPITATIONS 2813 0.0240
570 ARRHYTHMIA 1137 0.0240
571 MYALGIA 4082 0.0240
572 FLUID RETENTION 1221 0.0240
573 HYPERSOMNIA 687 0.0239
574 FOOT FRACTURE 454 0.0239
575 PNEUMONIA 7750 0.0239
576 HAEMATOCHEZIA 1320 0.0239
577 VITREOUS FLOATERS 235 0.0239
578 BLINDNESS 974 0.0239
579 CHROMATURIA 539 0.0239
580 PULMONARY HYPERTENSION 497 0.0238
581 NASAL CONGESTION 1402 0.0238
582 MUSCULOSKELETAL DISCOMFORT 410 0.0238
583 GASTROINTESTINAL INFECTION 213 0.0237
584 PNEUMONIA ASPIRATION 593 0.0237
585 BRAIN INJURY 238 0.0237
586 OEDEMA 1282 0.0236
587 JAUNDICE 635 0.0236
588 EMPHYSEMA 238 0.0236
589 DEPRESSED MOOD 1247 0.0236
590 ORAL CANDIDIASIS 310 0.0235
591 THYROID DISORDER 362 0.0235
592 PALLOR 639 0.0235
593 HEPATIC ENCEPHALOPATHY 219 0.0234
594 METASTASES TO LUNG 271 0.0234
595 HOT FLUSH 1767 0.0234
596 PSORIASIS 3062 0.0234
597 FATIGUE 18242 0.0234
598 GALLBLADDER DISORDER 418 0.0234
599 VISION BLURRED 3212 0.0234
600 MOVEMENT DISORDER 751 0.0234
601 EAR INFECTION 622 0.0234
602 INFUSION SITE PAIN 301 0.0233
603 OESOPHAGITIS 255 0.0233
604 INJECTION SITE BRUISING 1862 0.0233
605 MYOCARDIAL INFARCTION 4071 0.0233
606 ERECTILE DYSFUNCTION 598 0.0233
607 HALLUCINATION, AUDITORY 370 0.0233
608 EYE DISORDER 765 0.0232
609 PULMONARY EMBOLISM 2206 0.0232
610 SOMNOLENCE 4663 0.0231
611 PRODUCT ADMINISTRATION ERROR 468 0.0231
612 ORAL PAIN 518 0.0231
613 PRODUCT DOSE OMISSION 1507 0.0231
614 DYSPHONIA 1347 0.0230
615 DRUG DOSE OMISSION 3807 0.0230
616 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1638 0.0230
617 MUSCLE RIGIDITY 275 0.0230
618 TENDONITIS 356 0.0230
619 RESTLESS LEGS SYNDROME 418 0.0230
620 HALLUCINATION, VISUAL 485 0.0229
621 SKIN INFECTION 257 0.0229
622 SUDDEN DEATH 242 0.0228
623 CHOKING 446 0.0228
624 SCRATCH 241 0.0228
625 DISCOMFORT 1392 0.0228
626 DIPLOPIA 592 0.0228
627 EYE PAIN 1283 0.0227
628 SCAB 259 0.0227
629 CHOLESTASIS 436 0.0227
630 GENERALISED OEDEMA 281 0.0227
631 COVID-19 3980 0.0227
632 HYPOAESTHESIA 3395 0.0227
633 SARS-COV-2 TEST POSITIVE 299 0.0226
634 FEELING HOT 1387 0.0226
635 INCORRECT DOSE ADMINISTERED BY DEVICE 593 0.0226
636 ADRENAL INSUFFICIENCY 274 0.0226
637 ARTHRALGIA 9378 0.0225
638 NEPHROPATHY TOXIC 252 0.0224
639 PERICARDIAL EFFUSION 519 0.0224
640 MALIGNANT MELANOMA 300 0.0224
641 POLYNEUROPATHY 268 0.0224
642 PRURITUS GENERALISED 484 0.0224
643 RASH PRURITIC 1208 0.0223
644 OSTEOPOROSIS 915 0.0222
645 TRANSFUSION 233 0.0222
646 DRUG INTOLERANCE 2147 0.0222
647 CONTUSION 2134 0.0221
648 DEPRESSION 5043 0.0221
649 SKIN DISCOLOURATION 1017 0.0221
650 TREMOR 3670 0.0221
651 DEVICE LEAKAGE 957 0.0220
652 INJECTION SITE PAIN 6733 0.0219
653 INTESTINAL OBSTRUCTION 827 0.0219
654 ALANINE AMINOTRANSFERASE INCREASED 1345 0.0219
655 CARDIO-RESPIRATORY ARREST 916 0.0219
656 CHOLECYSTECTOMY 250 0.0219
657 LOCAL SWELLING 381 0.0218
658 FEELING JITTERY 416 0.0218
659 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3934 0.0218
660 MENTAL IMPAIRMENT 529 0.0218
661 DYSPHAGIA 2070 0.0218
662 HEPATIC FAILURE 657 0.0218
663 CARDIAC DISORDER 2036 0.0217
664 SWELLING 2035 0.0217
665 COELIAC DISEASE 212 0.0216
666 EYE INFECTION 244 0.0216
667 HYPOACUSIS 929 0.0216
668 MUSCULOSKELETAL STIFFNESS 1889 0.0215
669 EPISTAXIS 1611 0.0215
670 INJECTION SITE PRURITUS 1442 0.0215
671 APHONIA 300 0.0215
672 NERVOUSNESS 1121 0.0214
673 PRESCRIBED OVERDOSE 415 0.0214
674 NIGHTMARE 742 0.0214
675 PARAESTHESIA 3371 0.0214
676 GASTRIC DISORDER 734 0.0214
677 RESPIRATORY TRACT INFECTION 557 0.0214
678 CONDITION AGGRAVATED 6487 0.0213
679 ABDOMINAL PAIN LOWER 537 0.0212
680 VISUAL ACUITY REDUCED 705 0.0212
681 THERAPEUTIC PRODUCT EFFECT DECREASED 950 0.0212
682 HYPOAESTHESIA ORAL 319 0.0211
683 HEPATOTOXICITY 471 0.0211
684 SWELLING FACE 1377 0.0211
685 ALOPECIA 4145 0.0211
686 CEREBRAL HAEMORRHAGE 755 0.0211
687 SENSORY DISTURBANCE 338 0.0210
688 BRAIN FOG 330 0.0210
689 DEMENTIA 588 0.0210
690 ACUTE RESPIRATORY DISTRESS SYNDROME 372 0.0210
691 PRESCRIBED UNDERDOSE 419 0.0210
692 DRY THROAT 213 0.0209
693 CARDIOVASCULAR DISORDER 532 0.0209
694 INSURANCE ISSUE 320 0.0209
695 AMNESIA 1359 0.0209
696 DELUSION 324 0.0208
697 COGNITIVE DISORDER 973 0.0208
698 JOINT STIFFNESS 545 0.0208
699 FEELING ABNORMAL 4977 0.0207
700 HEAD DISCOMFORT 367 0.0207
701 DIALYSIS 294 0.0207
702 EXTRA DOSE ADMINISTERED 839 0.0207
703 BURNING SENSATION 1451 0.0207
704 RHEUMATOID ARTHRITIS 2348 0.0207
705 PRODUCT TASTE ABNORMAL 280 0.0207
706 SPEECH DISORDER 1083 0.0206
707 NEUROLEPTIC MALIGNANT SYNDROME 245 0.0206
708 MUSCLE TIGHTNESS 334 0.0206
709 INSOMNIA 5483 0.0206
710 INFUSION RELATED REACTION 1363 0.0205
711 TINNITUS 943 0.0205
712 BLOOD TEST ABNORMAL 287 0.0204
713 FLUSHING 2075 0.0204
714 ILLNESS 2100 0.0204
715 BLOOD ALKALINE PHOSPHATASE INCREASED 506 0.0204
716 INCORRECT DOSE ADMINISTERED 4640 0.0203
717 HEPATOCELLULAR INJURY 288 0.0203
718 POISONING 255 0.0203
719 HEADACHE 12711 0.0203
720 MACULAR DEGENERATION 242 0.0202
721 CEREBRAL INFARCTION 494 0.0202
722 DISTURBANCE IN ATTENTION 1088 0.0202
723 INTENTIONAL DOSE OMISSION 574 0.0201
724 ANXIETY 5722 0.0201
725 ADVERSE REACTION 266 0.0200
726 SYSTEMIC LUPUS ERYTHEMATOSUS 712 0.0200
727 JOINT DISLOCATION 212 0.0200
728 UPPER LIMB FRACTURE 399 0.0200
729 PLEURAL EFFUSION 1218 0.0200
730 BODY TEMPERATURE INCREASED 408 0.0200
731 COLON CANCER 298 0.0200
732 PAIN 12275 0.0200
733 OSTEOPENIA 303 0.0199
734 LACRIMATION INCREASED 601 0.0199
735 CHILLS 2328 0.0198
736 THROAT IRRITATION 891 0.0198
737 IMMUNODEFICIENCY 296 0.0198
738 PARAESTHESIA ORAL 286 0.0198
739 PANCYTOPENIA 1107 0.0198
740 PHOTOSENSITIVITY REACTION 327 0.0198
741 OCULAR DISCOMFORT 221 0.0197
742 RESPIRATORY DISORDER 588 0.0196
743 HERPES ZOSTER 1129 0.0196
744 DEEP VEIN THROMBOSIS 1276 0.0196
745 EPILEPSY 600 0.0196
746 PULMONARY THROMBOSIS 214 0.0196
747 COLITIS 744 0.0196
748 BLOOD CALCIUM DECREASED 220 0.0195
749 ASPARTATE AMINOTRANSFERASE INCREASED 1039 0.0195
750 EYE SWELLING 724 0.0194
751 PRURITUS 7470 0.0194
752 DERMATITIS CONTACT 221 0.0194
753 GENERALISED TONIC-CLONIC SEIZURE 320 0.0193
754 PREMATURE BABY 579 0.0192
755 ANOSMIA 277 0.0191
756 BEDRIDDEN 251 0.0191
757 INJECTION SITE DISCOLOURATION 238 0.0190
758 ATAXIA 226 0.0190
759 THROMBOSIS 1532 0.0190
760 LIVER DISORDER 843 0.0190
761 LYMPHOCYTE COUNT DECREASED 336 0.0190
762 TRANSAMINASES INCREASED 422 0.0190
763 STOMATITIS 1151 0.0190
764 TENDON RUPTURE 234 0.0189
765 THERAPY CESSATION 969 0.0189
766 DRUG ERUPTION 333 0.0188
767 RASH MACULO-PAPULAR 418 0.0188
768 FOETAL EXPOSURE DURING PREGNANCY 1519 0.0187
769 SKIN EXFOLIATION 1574 0.0186
770 PROCEDURAL PAIN 517 0.0186
771 SCAR 319 0.0186
772 PHARYNGEAL OEDEMA 286 0.0186
773 SKIN FISSURES 363 0.0186
774 ROAD TRAFFIC ACCIDENT 777 0.0186
775 VIRAL INFECTION 617 0.0185
776 HIP FRACTURE 596 0.0185
777 PHOTOPHOBIA 348 0.0185
778 MATERNAL EXPOSURE DURING PREGNANCY 1648 0.0185
779 MIGRAINE 1764 0.0185
780 ASCITES 543 0.0185
781 BACTERAEMIA 219 0.0184
782 PYREXIA 6359 0.0184
783 KNEE ARTHROPLASTY 386 0.0183
784 AGITATION 1344 0.0183
785 WRIST FRACTURE 219 0.0183
786 HALLUCINATION 1365 0.0181
787 PAIN IN JAW 512 0.0181
788 FULL BLOOD COUNT DECREASED 364 0.0180
789 RESTLESSNESS 656 0.0179
790 IMMUNE SYSTEM DISORDER 236 0.0179
791 DRUG PRESCRIBING ERROR 344 0.0179
792 BACTERIAL INFECTION 334 0.0179
793 PRODUCT USE ISSUE 3361 0.0179
794 PRODUCT QUALITY ISSUE 2424 0.0178
795 BONE PAIN 1042 0.0178
796 PARALYSIS 254 0.0177
797 METASTASES TO BONE 291 0.0177
798 LOWER LIMB FRACTURE 340 0.0177
799 BLOOD BILIRUBIN INCREASED 477 0.0176
800 URTICARIA 2957 0.0176
801 ORAL DISCOMFORT 245 0.0176
802 PRODUCT DOSE OMISSION IN ERROR 499 0.0176
803 TOOTH DISORDER 391 0.0176
804 PLATELET COUNT DECREASED 1870 0.0175
805 SKIN DISORDER 584 0.0175
806 HAEMORRHAGE INTRACRANIAL 260 0.0174
807 THINKING ABNORMAL 324 0.0174
808 MUSCLE TWITCHING 400 0.0173
809 PRODUCT SUBSTITUTION ISSUE 997 0.0173
810 DRUG DISPENSING ERROR 264 0.0173
811 THROAT TIGHTNESS 467 0.0172
812 SKIN REACTION 243 0.0172
813 INCORRECT PRODUCT ADMINISTRATION DURATION 371 0.0171
814 THERAPEUTIC RESPONSE UNEXPECTED 768 0.0171
815 OVERDOSE 3692 0.0171
816 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1217 0.0171
817 INFECTION 2471 0.0171
818 MULTI-ORGAN FAILURE 295 0.0170
819 APATHY 248 0.0170
820 LYMPHADENOPATHY 601 0.0170
821 ANAPHYLACTIC REACTION 937 0.0169
822 BONE DISORDER 309 0.0169
823 RASH MACULAR 592 0.0169
824 RASH 7380 0.0169
825 INFLUENZA LIKE ILLNESS 1393 0.0169
826 POST PROCEDURAL COMPLICATION 324 0.0169
827 DYSKINESIA 685 0.0168
828 EYE PRURITUS 566 0.0168
829 THERAPY INTERRUPTED 1199 0.0168
830 QUALITY OF LIFE DECREASED 225 0.0168
831 EXPIRED PRODUCT ADMINISTERED 557 0.0167
832 ADVERSE DRUG REACTION 1498 0.0167
833 DEVICE MALFUNCTION 1172 0.0167
834 MOOD ALTERED 454 0.0166
835 INJURY ASSOCIATED WITH DEVICE 337 0.0165
836 OFF LABEL USE 14478 0.0165
837 ANHEDONIA 434 0.0165
838 INJECTION SITE INDURATION 214 0.0165
839 STAPHYLOCOCCAL INFECTION 544 0.0165
840 GINGIVAL BLEEDING 225 0.0165
841 MENTAL DISORDER 717 0.0165
842 MUCOSAL INFLAMMATION 431 0.0164
843 PNEUMONITIS 448 0.0164
844 FEBRILE NEUTROPENIA 1089 0.0164
845 PRODUCT DOSE OMISSION ISSUE 4818 0.0164
846 BLOOD LACTATE DEHYDROGENASE INCREASED 259 0.0163
847 DISEASE RECURRENCE 777 0.0163
848 TREATMENT FAILURE 1351 0.0163
849 FACE OEDEMA 275 0.0163
850 DEAFNESS 426 0.0163
851 MUSCULOSKELETAL DISORDER 310 0.0163
852 INJECTION SITE URTICARIA 399 0.0162
853 INTERSTITIAL LUNG DISEASE 787 0.0162
854 RASH GENERALISED 420 0.0162
855 ABNORMAL DREAMS 447 0.0162
856 PANIC ATTACK 590 0.0162
857 RASH PAPULAR 362 0.0161
858 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 751 0.0161
859 SEROTONIN SYNDROME 308 0.0160
860 ABASIA 396 0.0160
861 ECONOMIC PROBLEM 242 0.0160
862 HYPERSENSITIVITY 2945 0.0158
863 DRUG EFFECT INCOMPLETE 576 0.0158
864 LUNG INFECTION 246 0.0158
865 PRODUCT PHYSICAL ISSUE 319 0.0158
866 PSYCHOTIC DISORDER 466 0.0158
867 DEVICE MECHANICAL ISSUE 216 0.0157
868 THERAPY NON-RESPONDER 708 0.0157
869 SPINAL FRACTURE 315 0.0157
870 FEAR 419 0.0156
871 ILL-DEFINED DISORDER 946 0.0156
872 THROMBOCYTOPENIA 1738 0.0155
873 DEVICE ISSUE 1383 0.0154
874 LABORATORY TEST ABNORMAL 455 0.0154
875 ERYTHEMA 3165 0.0154
876 PRODUCT DISPENSING ERROR 332 0.0152
877 PRODUCT USE COMPLAINT 240 0.0152
878 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 261 0.0152
879 PRODUCT USE IN UNAPPROVED INDICATION 3772 0.0152
880 CLOSTRIDIUM DIFFICILE INFECTION 332 0.0152
881 COLITIS ULCERATIVE 679 0.0152
882 DRY EYE 758 0.0152
883 AGRANULOCYTOSIS 282 0.0152
884 WHITE BLOOD CELL COUNT DECREASED 1643 0.0151
885 ECZEMA 789 0.0151
886 RASH ERYTHEMATOUS 719 0.0150
887 INJURY 1054 0.0150
888 ANGER 507 0.0150
889 MANIA 246 0.0149
890 PARANOIA 257 0.0149
891 DRUG ADMINISTRATION ERROR 452 0.0147
892 PAIN OF SKIN 394 0.0146
893 PRODUCT AVAILABILITY ISSUE 333 0.0146
894 DRUG INEFFECTIVE 19268 0.0146
895 EYE IRRITATION 837 0.0145
896 INJECTION SITE RASH 446 0.0145
897 HIP ARTHROPLASTY 222 0.0145
898 CYANOSIS 227 0.0144
899 MULTIPLE FRACTURES 236 0.0144
900 SEIZURE 1657 0.0143
901 ACTIVITIES OF DAILY LIVING IMPAIRED 284 0.0143
902 IRRITABILITY 862 0.0143
903 NEUTROPHIL COUNT DECREASED 584 0.0143
904 INJECTION SITE SWELLING 1087 0.0142
905 DEVICE FAILURE 216 0.0142
906 FEMUR FRACTURE 439 0.0142
907 SEDATION 371 0.0142
908 RESPIRATORY ARREST 389 0.0141
909 SKIN CANCER 301 0.0140
910 PNEUMOTHORAX 221 0.0139
911 THERAPEUTIC RESPONSE DECREASED 844 0.0139
912 MOUTH ULCERATION 293 0.0139
913 SURGERY 810 0.0138
914 DRUG EFFECT DECREASED 744 0.0138
915 OCULAR HYPERAEMIA 653 0.0137
916 SUICIDAL IDEATION 1248 0.0136
917 CRYING 495 0.0136
918 DRY SKIN 1818 0.0136
919 INJECTION SITE ERYTHEMA 1684 0.0136
920 THERAPEUTIC RESPONSE SHORTENED 450 0.0136
921 DERMATITIS 283 0.0135
922 PSYCHOMOTOR HYPERACTIVITY 220 0.0132
923 ABNORMAL BEHAVIOUR 523 0.0132
924 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 337 0.0131
925 ORAL HERPES 255 0.0131
926 DISEASE PROGRESSION 1543 0.0130
927 NEUTROPENIA 1759 0.0129
928 HAEMORRHAGE 1351 0.0129
929 INCORRECT DRUG ADMINISTRATION DURATION 361 0.0128
930 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 702 0.0128
931 MALIGNANT NEOPLASM PROGRESSION 1301 0.0127
932 AGGRESSION 627 0.0125
933 INJECTION SITE REACTION 862 0.0125
934 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 291 0.0125
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2529 0.0125
936 NERVOUS SYSTEM DISORDER 389 0.0125
937 FRACTURE 235 0.0124
938 WITHDRAWAL SYNDROME 521 0.0124
939 DEVICE USE ISSUE 214 0.0122
940 INTENTIONAL SELF-INJURY 246 0.0122
941 DISABILITY 234 0.0118
942 PELVIC PAIN 213 0.0117
943 INJECTION SITE WARMTH 241 0.0117
944 UNEVALUABLE EVENT 885 0.0117
945 VAGINAL HAEMORRHAGE 502 0.0116
946 ADVERSE EVENT 1062 0.0115
947 ANAPHYLACTIC SHOCK 297 0.0115
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 388 0.0115
949 NEOPLASM PROGRESSION 399 0.0115
950 DEVICE DELIVERY SYSTEM ISSUE 313 0.0114
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 415 0.0114
952 APPLICATION SITE PAIN 251 0.0114
953 MOOD SWINGS 357 0.0112
954 LEUKOPENIA 558 0.0111
955 HEPATIC FUNCTION ABNORMAL 407 0.0109
956 CYTOKINE RELEASE SYNDROME 215 0.0107
957 NEOPLASM MALIGNANT 714 0.0107
958 HOSPITALISATION 1632 0.0106
959 LUNG NEOPLASM MALIGNANT 433 0.0105
960 OSTEONECROSIS OF JAW 260 0.0105
961 PRODUCT PRESCRIBING ISSUE 228 0.0105
962 TOOTH LOSS 216 0.0104
963 PLASMA CELL MYELOMA 400 0.0102
964 EMOTIONAL DISORDER 315 0.0102
965 EMOTIONAL DISTRESS 1232 0.0102
966 PRODUCT STORAGE ERROR 855 0.0098
967 ABORTION SPONTANEOUS 375 0.0093
968 DEATH 8034 0.0093
969 TARDIVE DYSKINESIA 251 0.0089
970 DRUG RESISTANCE 228 0.0089
971 EXTRAPYRAMIDAL DISORDER 214 0.0086
972 DRUG ABUSE 702 0.0084
973 BONE DENSITY DECREASED 263 0.0084
974 APPLICATION SITE ERYTHEMA 220 0.0084
975 MULTIPLE SCLEROSIS 386 0.0081
976 DERMATITIS ATOPIC 413 0.0078
977 SKIN IRRITATION 353 0.0077
978 SKIN BURNING SENSATION 550 0.0077
979 PRODUCT ADHESION ISSUE 269 0.0075
980 MULTIPLE SCLEROSIS RELAPSE 512 0.0075
981 BREAST CANCER 653 0.0070
982 ACNE 512 0.0067
983 PROSTATE CANCER 527 0.0065
984 DEVICE DISLOCATION 275 0.0063
985 DEVICE BREAKAGE 252 0.0062
986 ACCIDENTAL EXPOSURE TO PRODUCT 617 0.0060
987 CONVULSION 338 0.0059
988 NO ADVERSE EVENT 974 0.0054
989 DRUG WITHDRAWAL SYNDROME 437 0.0050
990 RENAL CANCER 225 0.0047
991 DRUG DOSE OMISSION BY DEVICE 365 0.0047
992 DEVICE DIFFICULT TO USE 213 0.0032
993 DRUG DEPENDENCE 444 0.0028